Grace Therapeutics
GRCE
9 hedge funds and large institutions have $1.66M invested in Grace Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 6 closing their positions.
7% more capital invested
Capital invested by funds: $1.55M → $1.66M (+$104K)
1.4% less ownership
Funds ownership: 7.49% → 6.1% (-1.4%)
25% less funds holding
Funds holding: 12 → 9 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$73.4K |
| 2 |
Morgan Stanley
New York
|
+$4.46K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.11K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$97 |
| 5 |
IGWM
ICA Group Wealth Management
Denver,
Colorado
|
+$21 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TPCW
TD Private Client Wealth
New York
|
-$110K |
| 2 |
CBA
Coastal Bridge Advisors
Westport,
Connecticut
|
-$27.8K |
| 3 |
JP Morgan Chase
New York
|
-$9.2K |
| 4 |
IPW
Impact Partnership Wealth
Marietta,
Georgia
|
-$28 |
| 5 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Bank of America
Charlotte,
North Carolina
| $1.43M | – | – | – |
|
|
ACM
2
ADAR1 Capital Management
Austin,
Texas
| $99.8K | +$81.8K | +34,532 | New |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $92K | +$73.4K | +31,000 | +5,308% |
|
|
4
UBS Group
Zurich,
Switzerland
| $16.2K | +$2.11K | +890 | +19% |
|
|
5
Morgan Stanley
New York
| $10.9K | +$4.46K | +1,882 | +100% |
|
6
National Bank of Canada
Montreal,
Quebec, Canada
| $7.97K | – | – | – |
|
|
ASN
7
Advisory Services Network
Atlanta,
Georgia
| $118 | +$97 | +41 | New |
|
|
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $81 | – | – | – |
|
|
IGWM
9
ICA Group Wealth Management
Denver,
Colorado
| $26 | +$21 | +9 | New |
|
|
TPCW
10
TD Private Client Wealth
New York
| – | -$110K | -40,132 | Closed |
|
|
CBA
11
Coastal Bridge Advisors
Westport,
Connecticut
| – | -$27.8K | -10,000 | Closed |
|
|
12
JP Morgan Chase
New York
| – | -$9.2K | -3,358 | Closed |
|
|
IPW
13
Impact Partnership Wealth
Marietta,
Georgia
| – | -$28 | -10 | Closed |
|
|
TWC
14
TD Waterhouse Canada
Toronto,
Ontario, Canada
| – | -$4 | -1 | Closed |
|
GRCE Hedge Fund Activity: Q4 2023 in Review
9 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q4 2023, worth a combined $1.66M — up 6.7% from $1.55M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of GRCE and 3 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Royal Bank of Canada, adding an estimated $73.4K. The largest seller was TD Private Client Wealth, exiting entirely with an estimated $110K sold.
- 9 institutional investors held Grace Therapeutics (GRCE) as of Q4 2023, down from 12 in Q3 2023.
- Funds reported $1.66M of Grace Therapeutics stock for Q4 2023, up 6.7% quarter-over-quarter.
- 3 funds opened new Grace Therapeutics positions in Q4 2023 and 6 closed out, a net change of -3 holders.
- The largest Grace Therapeutics buyer in Q4 2023 was Royal Bank of Canada, an estimated $73.4K added.
- The largest Grace Therapeutics seller in Q4 2023 was TD Private Client Wealth, an estimated $110K sold.
Based on aggregated 13F filings for Q4 2023.